Plasma lipidomic signatures for risk prediction and prevention of gestational diabetes
Plasma lipidomic signatures for risk prediction and prevention of gestational diabetes
批准号:
nhmrc : GNT1161871
负责人:
Dr Aya Mousa
金额:
$32.72万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --
中文摘要
每年有超过20,000名澳大利亚妇女患上妊娠糖尿病(GDM),增加了她们患妊娠并发症以及糖尿病和心脏病的风险。脂质是细胞能量的关键来源,在怀孕期间经常发生变化,但它们在GDM中的作用尚不清楚。使用新的技术,我将测量数百种脂质,以检查某些脂质种类是否有助于GDM的发展,以及这些脂质是否被饮食,生活方式和/或药物治疗改变。
英文摘要
Over 20,000 Australian women develop gestational diabetes (GDM) annually, increasing their risk of pregnancy complications, as well as diabetes and heart disease later in life. Lipids are a key source of energy for cells and often change during pregnancy, yet their role in GDM is unknown. Using novel techniques, I will measure hundreds of lipids to examine whether certain lipid species contribute to GDM development and whether these lipids are altered by diet, lifestyle, and/or drug therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金